| Indication |
Phase |
Sample Size |
Study
Design/Services |
| Complications of CABG |
2 |
100 |
Randomized,
double-blind, placebo-controlled, parallel group, multi-center
proof of concept study |
| Complications of PCI |
3b |
900 |
Randomized,
multi-national, active-controlled, open-label study |
| Congestive Heart Failure |
N/A |
N/A |
Assisted in the preparation of an Investigator
Brochure |
| Coronary Artery Disease |
2 |
100 |
Open-label
study/
Provided statistical consulting services for
the study design, protocol development, case report form
development, sample size calculation and randomization |
| Healthy Subjects (Hypercholesterolemia) |
1 |
30 |
Single-center,
randomized, double-blind, placebo-controlled, single ascending
dose study |
| Healthy Subjects (Hypercholesterolemia) |
1 |
150 |
Single-center,
randomized, double-blind, placebo- and active-controlled, repeat
ascending dose study |
| Healthy Subjects (Platelet Function Disorders) |
1 |
50 |
Single-center,
double-blind, randomized, dose escalation study |
| Hypercholesterolemia |
2 |
150 |
Randomized,
multi-center, double-blind, placebo-controlled, parallel group,
dose-range finding study |
| Platelet Function Disorders |
2 |
30 |
Single-center,
open-label, pilot study |
| Thoracic Stent Graft |
1 |
50 |
Single arm study |
